Percutaneous irreversible electroporation (IRE) of hepatic malignant tumours: Contrast-enhanced ultrasound (CEUS) findings

Clinical Hemorheology and Microcirculation

Volumn 52, Issue 2-4, 2012, Pages 417-427

  Wiggermann, P ^a   Zeman, F ^a   Niessen C ^a   Agha, A ^a   Trabold, B ^a   Stroszczynski, C ^a   Jung, E M ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SONOVUE;

ABLATION THERAPY; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER THERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; MICROVASCULARIZATION; PERCUTANEOUS IRREVERSIBLE ELECTROPORATION; PROSPECTIVE STUDY; RADIOLOGIST; RETROSPECTIVE STUDY; TUMOR VASCULARIZATION;

ELECTROPORATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROCIRCULATION; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 84868618760     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2012-1615     Document Type: Article

References (29)

1. Ethical guidelines for publication in clinical hemorheology and microcirculation, Clinical Hemorheology and Microcirculation 44(1) (2010), 1-2.
2. L. Appelbaum, E. Ben-David, J. Sosna, Y. Nissenbaum and S.N. Goldberg, US findings after irreversible electroporation ablation: Radiologic-pathologic correlation, Radiology 262(1) (2012), 117-125.
3. R. Benz and U. Zimmermann, Pulse-length dependence of the electrical breakdown in lipid bilayer membranes, Biochimica et Biophysica Acta 597(3) (1980), 637-642.
4. K.P. Charpentier, F. Wolf, L. Noble, B. Winn, M. Resnick and D.E. Dupuy, Irreversible electroporation of the liver and liver hilum in swine, HPB: The official journal of the International Hepato Pancreato Biliary Association 13(3) (2011), 168-173.
5. C. Daniels and B. Rubinsky, Electrical field and temperature model of nonthermal irreversible electroporation in heterogeneous tissues, Journal of Biomechanical Engineering 131(7) (2009), 071006.
6. R.V.Davalos, I.L. Mir and B. Rubinsky, Tissue ablation with irreversible electroporation, Annals of Biomedical Engineering 33(2) (2005), 223-231. (Pubitemid 40496051)
7. A. Deodhar, T. Dickfeld, G.W. Single, WC Hamilton Jr, R.H. Thornton, C.T. Sofocleous, M. Maybody, M. Gonen, B. Rubinsky and S.B. Solomon, Irreversible electroporation near the heart: Ventricular arrhythmias can be prevented with ECG synchronization, AJR American journal of Roentgenology 196(3) (2011), W330-W335.
8. C. Greis, Quantitative evaluation of microvascular blood flowby contrast-enhanced ultrasound (CEUS), Clinical Hemorheology and Microcirculation 49(1-4) (2011), 137-149.
9. C. Greis, Ultrasound contrast agents as markers of vascularity and microcirculation, Clinical Hemorheology and Microcirculation 43(1-2) (2009), 1-9.
10. J.P. Guenette and D.E. Dupuy, Radiofrequency ablation of colorectal hepatic metastases, Journal of Surgical Oncology 102(8) (2010), 978-987.
11. P. Kamusella, P.Wiggermann, C.Wissgott, R. Andresen and C. Stroszczynski, [Thermal protection of targeted air instillation in CT-guided radiofrequency ablation], RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 183(10) (2011), 952-955.
12. R.T. Kubiniec, H. Liang and S.W. Hui, Effects of pulse length and pulse strength on transfection by electroporation, BioTechniques 8(1) (1990), 16-20. (Pubitemid 20031629)
13. E.W. Lee, C. Chen,V.E. Prieto, S.M. Dry, C.T. Loh and S.T.Kee, Advanced hepatic ablation technique for creating complete cell death: Irreversible electroporation, Radiology 255(2) (2010), 426-433.
14. E.W. Lee, C.T. Loh and S.T. Kee, Imaging guided percutaneous irreversible electroporation: Ultrasound and immunohistological correlation, Technology in Cancer Research & Treatment 6(4) (2007), 287-294.
15. R.C. Lee, Cell injury by electric forces, Ann N Y Acad Sci 1066 (2005), 85-91.
16. R. Lencioni and L. Crocetti, Local-regional treatment of hepatocellular carcinoma, Radiology 262(1) (2012), 43-58.
17. E. Maor, A. Ivorra, J. Leor and B. Rubinsky, The effect of irreversible electroporation on blood vessels, Technol Cancer Res Treat 6(4) (2007), 307-312. (Pubitemid 47340123)
18. R.C. Martin 2nd, K. McFarland, S. Ellis and V. Velanovich, Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma, Journal of the American College of Surgeons 215(3) (2012), 361-369.
19. L. Miller, J. Leor and B. Rubinsky, Cancer cells ablation with irreversible electroporation, Technol Cancer Res Treat 4(6) (2005), 699-705. (Pubitemid 43083355)
20. L.M. Mir, Nucleic acids electrotransfer-based gene therapy (electrogenetherapy): Past, current, and future, Molecular Biotechnology 43(2) (2009), 167-176.
21. G. Onik, P. Mikus and B. Rubinsky, Irreversible electroporation: Implications for prostate ablation, Technol Cancer Res Treat 6(4) (2007), 295-300. (Pubitemid 47340121)
22. P.M. Paprottka, C.C. Cyran, P. Zengel, J. von Einem, B. Wintersperger, K. Nikolaou, M.F. Reiser and D.A. Clevert, Non-invasive contrast enhanced ultrasound for quantitative assessment of tumor microcirculation. Contrast mixed mode examination vs. only contrast enhanced ultrasound examination, Clinical Hemorheology and Microcirculation 46(2-3) (2010), 149-158.
23. M. Pech, A. Janitzky, J.J.Wendler, C. Strang, S. Blaschke, O. Dudeck, J. Ricke and U.B. Liehr, Irreversible electroporation of renal cell carcinoma: A first-in-man phase I clinical study, Cardiovascular and Interventional Radiology 34(1) (2011), 132-138.
24. J. Rennert, M. Georgieva, A.G. Schreyer, W. Jung, C. Ross, C. Stroszczynski and E.M. Jung, Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors, Clinical Hemorheology and Microcirculation 49(1-4) (2011), 67-81.
25. M.P. Rols, Electropermeabilization, a physical method for the delivery of therapeutic molecules into cells, Biochimica et Biophysica Acta 1758(3) (2006), 423-428.
26. B. Rubinsky, G. Onik and P. Mikus, Irreversible electroporation: A new ablation modality-clinical implications, Technol Cancer Res Treat 6(1) (2007), 37-48. (Pubitemid 46389347)
27. L. Tiong and G.J. Maddern, Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma, The British Journal of Surgery 98(9) (2011), 1210-1224.
28. P. Wiggermann, R. Puls, A. Vasilj, D. Sieron, A.G. Schreyer, E.M. Jung, W. Wawrzynek and C. Stroszczynski, Thermal ablation of unresectable liver tumors: Factors associated with partial ablation and the impact on long-term survival, Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 18(2) (2012), CR88-CR92.
29. Y. Xia, Y.X. Jiang, Q. Dai, Y. Xiao, K. Lv and L. Wang, Contrast-enhanced ultrasound of hepatocellular carcinoma: Correlation of washout time and angiogenesis, Clinical Hemorheology and Microcirculation 48(4) (2011), 265-273.